Report overview
This report aims to provide a comprehensive presentation of the global market for Respiratory Syncytial Virus Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Syncytial Virus Vaccines. This report contains market size and forecasts of Respiratory Syncytial Virus Vaccines in global, including the following market information:
Global Respiratory Syncytial Virus Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Respiratory Syncytial Virus Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Palivizumab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Respiratory Syncytial Virus Vaccines include Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, GlaxoSmithKline, SOBI, Johnson & Johnson, Bavarian Nordic, Novavax and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Respiratory Syncytial Virus Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Syncytial Virus Vaccines Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, by Type, 2022 (%)
Palivizumab
RSVpreF PF06928316
RSVPreF3 OA (GSK3844766A)
mRNA-1345
Janssen RSV Vaccine
ResVax
Nirsevimab (MEDI8897)
MVA-BN RSV
Global Respiratory Syncytial Virus Vaccines Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Research Institute
Global Respiratory Syncytial Virus Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Respiratory Syncytial Virus Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Syncytial Virus Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Respiratory Syncytial Virus Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.Pfizer Inc.
Sanofi
Merck Sharp & Dohme
GlaxoSmithKline
SOBI
Johnson & Johnson
Bavarian Nordic
Novavax
AstraZeneca
Moderna
Codagenix
Intravacc
Alphavax
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Syncytial Virus Vaccines, market overview.
Chapter 2: Global Respiratory Syncytial Virus Vaccines market size in revenue.
Chapter 3: Detailed analysis of Respiratory Syncytial Virus Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Syncytial Virus Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
